Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 335 (ZNF335) is a protein that functions as a transcription factor and chromatin remodeling regulator. It enhances transcriptional activation by ligand-bound nuclear hormone receptors, not via direct receptor binding but by interacting with nuclear hormone receptor coactivator NRC. ZNF335 is a component of histone methyltransferase complexes (notably, the trithorax H3K4-methylation complex) and is critical for neural progenitor cell proliferation, self-renewal, proper nervous system development, and the regulation of gene expression relevant to somatic and brain development. Loss-of-function mutations in ZNF335 cause autosomal recessive microcephaly and other severe developmental syndromes[1][3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 335 (ZNF335).